Incidence of Infections and Predictors of Mortality During Checkpoint Inhibitor Immunotherapy in Patients With Advanced Lung Cancer: A Retrospective Cohort Study

BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized nonsmall cell lung cancer (NSCLC) treatment and significantly increased overall survival of patients. However, the incidence of concurrent infections and their management is still debated. METHODS: From August 2015 to October 2019,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Main Authors: Bavaro, Davide Fiore, Pizzutilo, Pamela, Catino, Annamaria, Signorile, Fabio, Pesola, Francesco, Di Gennaro, Francesco, Cassiano, Sandro, Marech, Ilaria, Lamorgese, Vito, Angarano, Gioacchino, Monno, Laura, Saracino, Annalisa, Galetta, Domenico
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2021
Assuntos:
Major Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8204890/
https://ncbi.nlm.nih.gov/pubmed/34141817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab187
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares